Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Key Points: Chemically modified nonanticoagulant heparins are strong inhibitors of hepcidin expression in normal and Bmp6−/− mice. These heparins abolish hepcidin induction caused by LPS, a model of inflammation, and are candidates for treatment of inflammatory anemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120
Hentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Heparan sulphate proteoglycans fine-tune mammalian physiology
Bishop, J. R., Schuksz, M., & Esko, J. D. (2007) · Nature · doi:10.1038/nature05817 · Cited by 1,631
Hentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292
Ganz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Liver hepcidin expression is controlled primarily by the bone morphogenetic protein (BMP)/sons of mothers against decapentaplegic (SMAD) signaling pathway.(15,16) Hemojuvelin (HJV) acts as aBMPcoreceptor(15,17,18) and itsmodulation by proteases participates in the control of hepcidin expression.”
BackgroundInterleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983
Chemistry and biology of eukaryotic iron metabolism
Aisen, P. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00063-2 · Cited by 804
Research works printed but not linked: 34
- Arosio, 2002, Ferritin, iron homeostasis, and oxidative damage., Free Radic Biol Med, 33, 457, 10.1016/S0891-5849(02)00842-0 · DOI · Paper page
- Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization., Science, 306, 2090, 10.1126/science.1104742 · DOI · Paper page
- Samad, 2005, DRAGON, a bone morphogenetic protein co-receptor., J Biol Chem, 280, 14122, 10.1074/jbc.M410034200 · DOI · Paper page
- Silvestri, 2009, Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia., Blood, 113, 5605, 10.1182/blood-2008-12-195594 · DOI · Paper page
- Roth, 2009, [BMP6: a key player in iron metabolism]., Med Sci (Paris), 25, 678, 10.1051/medsci/2009258-9678 · DOI
- Chung, 2010, Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone., FASEB J, 24, 2093, 10.1096/fj.09-152561 · DOI · Paper page
- Sun, Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation., 10.1002/ajh.23110 · DOI · Paper page
- Sakurai, 1993, [Purification of bone morphogenetic protein and investigation of its effects on osteoblastic cell line UMR108]., Kokubyo Gakkai Zasshi, 60, 169, 10.5357/koubyou.60.169 · doi:10.5357/koubyou.60.169
- Jiao, 2007, Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells., J Biol Chem, 282, 1080, 10.1074/jbc.M513414200 · DOI · Paper page
- Ruppert, 1996, Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity., Eur J Biochem, 237, 295, 10.1111/j.1432-1033.1996.0295n.x · DOI · Paper page
- Kanzaki, 2008, Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor., J Cell Physiol, 216, 844, 10.1002/jcp.21468 · DOI
- Zhao, 2006, Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2., J Biol Chem, 281, 23246, 10.1074/jbc.M511039200 · DOI · Paper page
- Takada, 2003, Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins., J Biol Chem, 278, 43229, 10.1074/jbc.M300937200 · DOI · Paper page
- Brkljacic, 2013, Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity., Int Orthop, 37, 529, 10.1007/s00264-012-1714-3 · DOI
- Casu, 2002, Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans., Semin Thromb Hemost, 28, 335, 10.1055/s-2002-34302 · DOI
- Turnbull, 2001, Heparan sulfate: decoding a dynamic multifunctional cell regulator., Trends Cell Biol, 11, 75, 10.1016/S0962-8924(00)01897-3 · DOI · Paper page
- Mulloy, 2006, Cytokines and proteoglycans: an introductory overview., Biochem Soc Trans, 34, 409, 10.1042/BST0340409 · DOI
- Ritchie, 2011, SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis., Clin Cancer Res, 17, 1382, 10.1158/1078-0432.CCR-10-2476 · DOI · Paper page
- Presta, 2003, Heparin derivatives as angiogenesis inhibitors., Curr Pharm Des, 9, 553, 10.2174/1381612033391379 · DOI · Paper page
- Casu, 2010, Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer., Matrix Biol, 29, 442, 10.1016/j.matbio.2010.04.003 · DOI
- Naggi, 2005, Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting., J Biol Chem, 280, 12103, 10.1074/jbc.M414217200 · DOI · Paper page
- Conrad, 1992, Structural analysis of periodate-oxidized heparin., Adv Exp Med Biol, 313, 31, 10.1007/978-1-4899-2444-5_3 · doi:10.1007/978-1-4899-2444-5_3
- Mousa, 2002, Anticoagulants in thrombosis and cancer: the missing link., Semin Thromb Hemost, 28, 45, 10.1055/s-2002-20559 · DOI
- Castagna, 2010, Hepcidin assay in serum by SELDI-TOF-MS and other approaches., J Proteomics, 73, 527, 10.1016/j.jprot.2009.08.003 · DOI
- Dongiovanni, 2013, Dietary iron overload induces visceral adipose tissue insulin resistance., Am J Pathol, 182, 2254, 10.1016/j.ajpath.2013.02.019 · DOI · Paper page
- Tjalsma, 2011, Mass spectrometry analysis of hepcidin peptides in experimental mouse models., PLoS ONE, 6, e16762, 10.1371/journal.pone.0016762 · DOI · Paper page
- Roetto, 2010, Comparison of 3 Tfr2-deficient murine models suggests distinct functions for Tfr2-alpha and Tfr2-beta isoforms in different tissues., Blood, 115, 3382, 10.1182/blood-2009-09-240960 · DOI · Paper page
- Cooke, 2013, A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates., Blood, 122, 3054, 10.1182/blood-2013-06-505792 · DOI · Paper page
- Malmström, 2012, Iduronic acid in chondroitin/dermatan sulfate: biosynthesis and biological function., J Histochem Cytochem, 60, 916, 10.1369/0022155412459857 · DOI · Paper page
- Casu, 2001, Structure and biological interactions of heparin and heparan sulfate., Adv Carbohydr Chem Biochem, 57, 159, 10.1016/S0065-2318(01)57017-1 · DOI · Paper page
- Naggi, Glycol-splitting as a device for modulating inhibition of growth factors and heparanase by heparin and heparin derivatives., 10.1016/B978-008044859-6/50017-4 · doi:10.1016/b978-008044859-6/50017-4
- Casu, 2004, Undersulfated and glycol-split heparins endowed with antiangiogenic activity., J Med Chem, 47, 838, 10.1021/jm030893g · DOI
- Kragh, 2005, Non-anti-coagulant heparins: a promising approach for prevention of tumor metastasis (review). [review], Int J Oncol, 27, 1159
- Babitt, 2007, Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance., J Clin Invest, 117, 1933, 10.1172/JCI31342 · DOI · Paper page
Cited by
Iron metabolism and iron disorders revisited in the hepcidin era
Camaschella, C., Nai, A., & Silvestri, L. (2020) · Haematologica · doi:10.3324/haematol.2019.232124 · Cited by 734
Targeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352
Pharmacological Targeting of the Hepcidin/Ferroportin Axis
Sebastiani, G., Wilkinson, N., & Pantopoulos, K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00160 · Cited by 127
Hepcidin antagonists for potential treatments of disorders with hepcidin excess
Poli, M., Asperti, M., Ruzzenenti, P., Regoni, M., & Arosio, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00086 · Cited by 124
Self-citationAnemia of chronic disorders: new diagnostic tools and new treatment strategies
Weiss, G. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.07.004 · Cited by 116
Metadata
- Authors
- Poli, M., Asperti, M., Naggi, A., Campostrini, N., Girelli, D., Corbella, M., Benzi, M., Besson-Fournier, C., Coppin, H., Maccarinelli, F., Finazzi, D., & Arosio, P.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2014-03-06
- Volume
- 123
- Issue
- 10
- Pages
- 1564-1573
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1968893403
- Cited by
- 69
- References
- 24
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. https://app.cochat.ai/papers/10.1182/blood-2013-07-515221
- The paper
- Poli, M., Asperti, M., Naggi, A., Campostrini, N., Girelli, D., Corbella, M., Benzi, M., Besson-Fournier, C., Coppin, H., Maccarinelli, F., Finazzi, D., & Arosio, P. (2014). Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. Blood. https://doi.org/10.1182/blood-2013-07-515221
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.